Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France
<p>Abstract</p> <p>Background</p> <p>Five diseases are currently screened on dried blood spots in France through the national newborn screening programme. Tandem mass spectrometry (MS/MS) is a technology that is increasingly used to screen newborns for an increasing num...
Main Authors: | Hamers Françoise F, Rumeau-Pichon Catherine |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-06-01
|
Series: | BMC Pediatrics |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2431/12/60 |
Similar Items
-
Clinical, Biochemical, and Molecular Analyses of Medium-Chain Acyl-CoA Dehydrogenase Deficiency in Chinese Patients
by: Zhuwen Gong, et al.
Published: (2021-03-01) -
Neonatal Screening for Medium-Chain Acyl-CoA Dehydrogenase Deficiency—Alternative Approaches
by: Rodney J. Pollitt
Published: (2016-03-01) -
Prevalence and Mutation Analysis of Short-Chain acyl-CoA Dehydrogenase Deficiency Detected by Newborn Screening in Hefei, China
by: Haili Hu, et al.
Published: (2024-10-01) -
Neonatal Screening for Medium-Chain Acyl-CoA Deficiency—Insights and Unexpected Challenges
by: Esther M. Maier
Published: (2015-11-01) -
Low Fasting Concentrations of Glucagon in Patients with Very Long-Chain Acyl-CoA Dehydrogenase Deficiency
by: Rasmus Stenlid, et al.
Published: (2023-06-01)